RADIANT_2A: RADIANT, figure 2A

RADIANT_2AR Documentation

RADIANT, figure 2A

Description

Kaplan-Meier digitized data from RADIANT, figure 2A (PMID 26324372). A reported sample size of 973 for a primary endpoint of DFS in lung cancer.

Usage

RADIANT_2A

Format

A data frame of 973 observations and 3 variables:

time event time (in months)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (erlotinib, placebo)

Source

Kelly K, Altorki NK, Eberhardt WEE, et al. Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial. J Clin Oncol 2015; 33: 4007–14.

Examples

summary(RADIANT_2A)

kmplot(RADIANT_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.